NanoDx, Inc.

📍 Southborough, United States🗓 Founded 2010👥 34 employees💰 Last funded May 2012
Medical Device🌐 nanodiagnostics.com
Website LinkedIn
NanoDx, Inc. is a privately-held, U.S. based, medical device company developing rapid point-of-care and in-vitro diagnostic products on its proprietary nanowire biosensor platform. The NanoDx™ System provides for direct measurement of blood and saliva analytes normally in less than 2 minutes from either a drop of whole blood or a small sample of saliva. In partnership with IBM and SkyWater Technologies, a low-cost, high-volume, licensed CMOS process has been integrated into NanoDx’s highly-advanced proprietary platform. The System consists of a single-use, disposable test cartridge and an analyzer. The company is focused on two near-term indications: traumatic brain injury (TBI) and Covid-19. The NanoDx™ System offers compelling competitive advantages based on its ultra-sensitivity and accuracy, speed, value, and ease-of-use. Additional potential diseases and conditions include stroke, sepsis, influenza and inflammatory diseases. FDA has not yet reviewed this product and it has not been cleared. Currently for research use only.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in NanoDx, Inc.?
NanoDx, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NanoDx, Inc. last raise funding?
The most recent investment in NanoDx, Inc. recorded on gritt.io was in May 2012.
When was NanoDx, Inc. founded?
NanoDx, Inc. was founded in 2010.
What industry is NanoDx, Inc. in?
NanoDx, Inc. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is NanoDx, Inc. based?
NanoDx, Inc. is headquartered in Southborough, United States.